Y, Z., S, M., A, W., E, G., GM, A., DM, L., & AC, L. (2023). Comprehensive epithelial biomarker analysis of malignant mesothelioma: EpCAM positivity is a potential diagnostic pitfall. Cancer cytopathology, 131(8), 507. https://doi.org/10.1002/cncy.22706
Chicago Style (17th ed.) CitationY, Zhu, Moore S, Wang A, George E, Allard GM, Libert DM, and Lowe AC. "Comprehensive Epithelial Biomarker Analysis of Malignant Mesothelioma: EpCAM Positivity Is a Potential Diagnostic Pitfall." Cancer Cytopathology 131, no. 8 (2023): 507. https://doi.org/10.1002/cncy.22706.
MLA (9th ed.) CitationY, Zhu, et al. "Comprehensive Epithelial Biomarker Analysis of Malignant Mesothelioma: EpCAM Positivity Is a Potential Diagnostic Pitfall." Cancer Cytopathology, vol. 131, no. 8, 2023, p. 507, https://doi.org/10.1002/cncy.22706.